text_1: U.S. Panel Questions Prostate Screening
text_2: This story describes the newly released recommendations of the U.S. Preventive Services Task Force on the utility of routine PSA testing. It highlighted the importance of the new recommendation, namely that the task force indicated that routine testing of men older than 75 resulted in little to no benefit. The story attempted to provide a picture for the reader of reasons for the ambiguity about routine prostate cancer screening and the important trade-off between common side effects and treatment of a disease that often is not problematic. It included quotes from experts who had different opinions about how to consider the risks and benefits of routine testing for, and various treatment of, prostate cancer.